Japan Bioindustry Association

1
July 2008 Japan Bioindustry Association
 Organization (1/2)
JBA is a non-profit organization dedicated to the promotion of bioscience,
biotechnology and bioindustry.

Board of Directors Representatives from both industry and academia

Chairman: President : Executive Director :

Dr. Hiroshi Harada Dr. Ichiro Kitasato Mr. Yoshiaki Tsukamoto
Professor Emeritus, Chief Corporate Advisor, Former Director General,
University of Tsukuba Meiji Seika Kaisha, Ltd. Shikoku Bureau of Economy,
Trade and Industry
Former Professor,
Tokyo Institute of Technology
2
Japan Bioindustry Association
Organization (2/2)
History
1987 JBA was established.
1942 The predecessor organization, Japanese Association of Industrial
Fermentation was established.

Members
210 companies from many industrial sectors
88 public organizations
about 1000 individuals

Staff
about 40

Budget (2008)
1.63 bil. yen = about 15.5 mil. USD (105 yen = 1 USD)

3
Japan Bioindustry Association
Main Activities
Act. 1: Assistance for Government Policymaking
Act. 2: Strategic Utilization of Genetic Resources
Act. 3: Biosafety and Public Awareness
Act. 4: Standardization and Intellectual Property
Act. 5: Support for Biotech Start-ups
Act. 6: BioJapan – The Longest-Established Bioindustry Event
Act. 7: Promotion of Science and Technology
Act. 8: Research and Development Projects
Act. 9: Others
4
Japan Bioindustry Association
 Activity 1:
Assistance for Government Policymaking
 Proposal for government policymaking
 Public-Private Joint Committee for Strategic Promotion of
Biotechnology (2008)
- under planning new strategy -
 New 5 Yearly Clinical Trial Activation Plan (2007)
 The Comprehensive National Biotech Strategy (2002)

 Contribution to construction of appropriate safety

regulation
 Law Concerning the Conservation and Sustainable Use of Biological
Diversity through Regulations on the Use of Living Modified
Organisms
 Law Concerning Prevention of Infection of Infectious Diseases and
Patients with Infectious Diseases The Comprehensive
 Guidelines for Protection of Personal Genetic Information National Biotech Strategy
 Ethical Guideline for Human Genome Analysis
 Certification and indication for biotech food

 International contribution to promotion of bioindustry and

harmonization of regulation
 JBA has sent its staff to OECD since 1991
 JBA staff participate in the meetings of Convention on Biological
Diversity, Biological Weapons Convention, etc.
OECD

5
Japan Bioindustry Association
 Activity 2:
Strategic Utilization of Genetic Resources

 History
 ODA project “Conservation and Sustainable Us
e of Tropical Bioresources" with the total budget
of about one billion yen between 1993 and 1998
 Support for infrastructures NITE Biological Resource Center
 NITE*) Biological Resource Center (N-BRC) est
ablished in 2002
 Joint Research Agreement on the
microorganism taxonomy of six countries
(Indonesia, Vietnam, Myanmar, Thailand,
China, and Mongolia)
 User-specific and friendly “Guidelines on Acces
s to Genetic Resources” by the Ministry of Econ
omy, Trade and Industry and JBA

*) National Institute of Technology and Evaluation Guidelines on Access to

Genetic Resources for
Japanese Users 6
Japan Bioindustry Association
 Activity 3:
Biosafety and Public Awareness

 Biosafety
 Support for discussions in OECD
 Support for discussions in Convention on
Biological Diversity
 JBA established “DataBiosafety for the Industrial
Application of Microprobes” that helps biotech
companies to apply for approval to the DataBiosafety for the Indu
government. strial Application of Microp
 Public Awareness robes
 Training of corporate employees who truly http://diam-jba.jp
understands biotechnology and can communicate
better with their customers and the public
 Practical Training of School teachers
 Researches on social and ethical issues in
bioindustry since 2002
 A website “bio-school” to learn from basis to
applications of bioindustry
Training of teachers (2007)
7
Japan Bioindustry Association
Activity 4:
Standardization and Intellectual Property
 Standardization
 International standardization for sound
development of industry
 International Standards produced by JBA and the
other organizations
 ISO21571: Foodstuffs - Methods of analysis for

the detection of the genetically modified Report meeting by JBA

organisms and derived products - Nucleic acid Intellectual Property
extraction Working Group （ 2006 ）
 ISO14855-2: Test Method of Biodegradable and

Bio-based Polymer
 Intellectual property
 Proposal to the government
 New function of a gene

 Research tool patent: protection and utilization

 Medical procedures

 Functional foods

8
Japan Bioindustry Association
 Activity 5:
Support for Biotech Start-ups

 Statistics 600
531
586

586 companies in Japan in 2006

500 464

 400
333
387

304

(575 private and 11 public)

300 254
212
200 167
132 150
102 116
100

 Partnering events 0
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006

Statistics
 Bio-cluster “Metropolitan Bio Network”
 Since 2002
 About 400 companies

 Free business consultation

Partnering events

9
Japan Bioindustry Association
 Activity 6:
BioJapan – The Longest-Established Bioindustry Event
 Since 1986
 BioJapan 2008 World
Business Forum will be
held on Oct. 15th to
17th, 2008
http://expo.nikkeibp.co.jp/biojap
an/eng/index.html
 Contents
 Exhibition
 Partnering
 Seminar
BioJapan 2007

10
Japan Bioindustry Association
 Activity 7:
Promotion of Science and Technology

 “Green Biotechnology Strategy Forum”

 Sustainable development of industry
through biotechnology
International Workshop
 35 major companies （ 2007 ）

 International Workshop (2005, 2007)

 Traditional study groups

 Fermentation & Metabolism
 Bioengineering
 Bioconversion of new resources Symposium on Amino
Acid Fermentation
 Alcohol & Biomass （ 2007 ）

11
Japan Bioindustry Association
 Activity 8:
Research and Development Projects
 Advanced national projects
 Production of new antibodies
 Bioprocess using microbial functions
 Cell array for analysis of gene function
 Microbial genetic resource library
 The four projects above:
 budjet in 2007: 1.13 bil. yen in total (= about 10.8 mil. USD )
Anti-glypican 3 antibody
 43 companies, 33 universities ,11 national institutes and 352
mAb1, mAb2 for serodiagnosis
researchers in total
mAb3 for pathological use
mAb4 for medicinal use
 Achievement - example
 14 projects between 1997-2007 （Ｂ）
 94 companies, 84 universities, 31 national institutes and 3,175
researchers in total
 From the project on protein analysis from 1999 to 2005
 Anti-glypican 3 antibody: prepared for clinical test by Chugai
 Anti-Pentraxin 3 antibody: prepared for clinical test as diagnosis for
arterial sclerosis and cardiac infarction
（Ａ）
 Antibodies against all types of Nuclear receptor: launched as
research use agents
（Ｃ）
 From the project on biomass plastics
 Verification test of biomass plastics in the site of the Aichi Expo in Biomass Plastics in the
2005 Aichi Expo （ 2005 ）
 Supermarkets and a food chain introduced biomass plastics to (A) “One-way”: disposable with garbage
their shops in whole Japan, and the new industry of 300 tons per (B) “Returnable”
year was created. (C) garbage bag

12
Japan Bioindustry Association
 Activity 9:
Others

 Human resource development

 Domestic
 International:
JBA has received trainees from developing co
untries with JICA’s fund since 1988.
(178 trainees of 30 countries in total)
 Research fund International human
resource development
 Domestic: (2007)
One JBA award (prize: one million yen) and g
rant (total 4.5 million yen) for 10 researches in
2007
 “Bioscience and Bioindustry”, JBA’s month
ly journal
 The 65th anniversary in publication in 2007
 About 2500 subscribes
 Trends of research, industry and administratio
n Awards ceremony (2007) “Bioscience
and Industry”

13
Japan Bioindustry Association